Sign in

CIK 0001763950

  • Non-accelerated filer
  • Smaller reporting company

Lantern Pharma Inc.

Sign in to watch
Ticker
LTRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TX
Entity type
Operating
EIN
463973463
Phone
+1 972-277-1136
Business address
1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS, TX, 75201
Former names
Lantern Pharma
  1. 4 Open-market sale 10% owner sold 61,613 shares at an average $3.38 ($208,271)
  2. 4 Open-market sale 10% owner sold 56,237 shares at an average $2.99 ($168,419)
  3. 4 Open-market sale 10% owner sold 56,237 shares at an average $2.99 ($168,419)
  4. 4 Option exercise Director acquired 3,832 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale 10% owner sold 30,000 shares at an average $6.30 ($189,100)
  13. 4 Open-market sale 10% owner sold 30,000 shares at an average $6.30 ($189,100)
  14. 4 Open-market sale 10% owner sold 144,000 shares at an average $4.70 ($676,294)
  15. 4 Open-market sale 10% owner sold 144,000 shares at an average $4.70 ($676,294)
  16. 4 Open-market sale 10% owner sold 58,889 shares at $4.20 ($247,334)
  17. 4 Open-market sale 10% owner sold 58,889 shares at $4.20 ($247,334)
  18. 4 Open-market sale 10% owner sold 145,348 shares at $3.44 ($499,997)
  19. 4 Open-market sale 10% owner sold 145,348 shares at $3.44 ($499,997)
  20. 4 Open-market sale 10% owner sold 350,000 shares at $4.40 ($1,540,000)

Page 2 of 4 · 79 filings